{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:20:19Z","timestamp":1777998019323,"version":"3.51.4"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AR073935"],"award-info":[{"award-number":["RO1AR073935"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.trsl.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T19:46:38Z","timestamp":1646163998000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Targeting DAMPs with nucleic acid scavengers to treat lupus"],"prefix":"10.1016","volume":"245","author":[{"given":"Lyra B.","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole I.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Rempel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-5541","authenticated-orcid":false,"given":"Bruce A.","family":"Sullenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2022.02.007_bib0001","first-page":"240","article-title":"Lupus: an overview of the disease and management options","volume":"37","author":"Maidhof","year":"2012","journal-title":"P T"},{"key":"10.1016\/j.trsl.2022.02.007_bib0002","first-page":"330","article-title":"Manifestations of systemic lupus erythematosus","volume":"6","author":"Cojocaru","year":"2011","journal-title":"Maedica (Bucur)"},{"issue":"1","key":"10.1016\/j.trsl.2022.02.007_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antib5010002","article-title":"Autoantibodies in SLE: specificities, isotypes and receptors","volume":"5","author":"Dema","year":"2016","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.trsl.2022.02.007_bib0004","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells' contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2022.02.007_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108445","article-title":"Update on the cellular and molecular aspects of lupus nephritis","volume":"216","author":"Frangou","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0007","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.semnephrol.2015.08.003","article-title":"Neutrophils, dendritic cells, toll-like receptors, and interferon-alpha in lupus nephritis","volume":"35","author":"Lorenz","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4172\/2155-9899.1000139","article-title":"neutrophil extracellular traps and systemic lupus erythematosus","volume":"4","author":"Yu","year":"2013","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA\u2013peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci translational med"},{"key":"10.1016\/j.trsl.2022.02.007_bib0010","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-\u03b1 in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.02.007_bib0011","doi-asserted-by":"crossref","first-page":"17331","DOI":"10.3390\/ijms160817331","article-title":"Infections and systemic lupus erythematosus: binding or sparring partners?","volume":"16","author":"Rigante","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2022.02.007_bib0012","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.168.3.1169","article-title":"The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo","volume":"168","author":"Johnson","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2022.02.007_bib0013","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.4049\/jimmunol.170.6.3243","article-title":"Pre-existing glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptor-dependent respiratory burst: potential role in the perpetuation of immune nephritis","volume":"170","author":"Suzuki","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0015","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Kariko","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2022.02.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6978936","article-title":"The role of toll-like receptor 4 in infectious and noninfectious inflammation","volume":"2016","author":"Molteni","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.trsl.2022.02.007_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.08.010","article-title":"Toll-like receptor signaling in cell proliferation and survival","volume":"49","author":"Li","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.trsl.2022.02.007_bib0018","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.trsl.2022.02.007_bib0019","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4049\/jimmunol.1801167","article-title":"Upregulation of proinflammatory bradykinin peptides in systemic lupus erythematosus and rheumatoid arthritis","volume":"205","author":"Vanarsa","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Frontiers in immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0021","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00281-019-00771-2","article-title":"Resolution of inflammation: from basic concepts to clinical application","volume":"41","author":"Neurath","year":"2019","journal-title":"Seminars in Immunopathol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0022","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10495-010-0478-8","article-title":"Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players","volume":"15","author":"Kruse","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.trsl.2022.02.007_bib0023","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0024","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.autrev.2008.07.046","article-title":"Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention","volume":"8","author":"Kim","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2022.02.007_bib0025","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/aps.2015.91","article-title":"Toll-like receptors: potential targets for lupus treatment","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2022.02.007_bib0026","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.02.007_bib0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2012.04.006","article-title":"The origin and properties of extracellular DNA: from PAMP to DAMP","volume":"144","author":"Pisetsky","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0028","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/rheumatology\/kex314","article-title":"Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease","volume":"56","author":"de Leeuw","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.trsl.2022.02.007_bib0029","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fimmu.2019.00502","article-title":"Cell-Free DNA as a biomarker in autoimmune rheumatic diseases","volume":"10","author":"Duvvuri","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.trsl.2022.02.007_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1196\/annals.1348.005","article-title":"TLR9 and the recognition of self and non-self nucleic acids","volume":"1082","author":"Lamphier","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.trsl.2022.02.007_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3638562","article-title":"Programmed cell death pathways in the pathogenesis of systemic lupus erythematosus","volume":"2019","author":"Yang","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.trsl.2022.02.007_bib0032","first-page":"372","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","author":"Lo","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.02.007_bib0033","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-3083.1989.tb01188.x","article-title":"Binding properties of human anti-DNA antibodies to cloned human DNA fragments","volume":"30","author":"Sano","year":"1989","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0034","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1177\/0961203320957717","article-title":"Cell-free DNA profiling in patients with lupus nephritis","volume":"29","author":"Truszewska","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.trsl.2022.02.007_bib0035","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw"},{"key":"10.1016\/j.trsl.2022.02.007_bib0036","doi-asserted-by":"crossref","first-page":"e13010","DOI":"10.1111\/eci.13010","article-title":"Microparticles as autoantigens in systemic lupus erythematosus","volume":"48","author":"Mobarrez","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2022.02.007_bib0037","article-title":"The role of nucleases and nucleic acid editing enzymes in the regulation of self-nucleic acid sensing","volume":"12","author":"Santa","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0038","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrneph.2011.197","article-title":"A novel pathogenetic concept-antiviral immunity in lupus nephritis","volume":"8","author":"Migliorini","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0039","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0b013e32832e089e","article-title":"Type I interferon and lupus","volume":"21","author":"Ronnblom","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12929-018-0436-2","article-title":"Toll-like receptors in lupus nephritis","volume":"25","author":"Devarapu","year":"2018","journal-title":"J Biomedical Sci"},{"key":"10.1016\/j.trsl.2022.02.007_bib0041","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfl336","article-title":"Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice","volume":"21","author":"Patole","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2022.02.007_bib0042","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1681\/ASN.2004100820","article-title":"Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells","volume":"16","author":"Patole","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0043","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2022.02.007_bib0044","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/art.23407","article-title":"Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis","volume":"58","author":"Savarese","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2022.02.007_bib0045","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/eji.201344283","article-title":"Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus","volume":"44","author":"Umiker","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0046","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1096\/fj.03-0646fje","article-title":"Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice","volume":"18","author":"Anders","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2022.02.007_bib0047","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20050338","article-title":"Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus","volume":"202","author":"Christensen","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2022.02.007_bib0048","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20082316","article-title":"Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing","volume":"206","author":"Fukui","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2022.02.007_bib0049","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2014.10.004","article-title":"Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage","volume":"31","author":"Dai","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0050","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/rheumatology\/keh693","article-title":"SLE\u2013a disease of clearance deficiency?","volume":"44","author":"Munoz","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.trsl.2022.02.007_bib0051","doi-asserted-by":"crossref","first-page":"e57082","DOI":"10.1371\/journal.pone.0057082","article-title":"Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells","volume":"8","author":"Fossati-Jimack","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.trsl.2022.02.007_bib0052","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"International Consortium for Systemic Lupus Erythematosus","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2022.02.007_bib0053","doi-asserted-by":"crossref","first-page":"15838","DOI":"10.1073\/pnas.1001337107","article-title":"Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus","volume":"107","author":"Shen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2022.02.007_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003336","article-title":"MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus","volume":"9","author":"Deng","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2022.02.007_bib0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s10875-013-9887-0","article-title":"Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation","volume":"33","author":"Chauhan","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0056","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00281-006-0034-3","article-title":"The role of toll-like receptors in systemic lupus erythematosus","volume":"28","author":"Rahman","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0057","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cei.13022","article-title":"Relevant genetic polymorphisms and kidney expression of Toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis","volume":"190","author":"Elloumi","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0058","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1073\/pnas.0501165102","article-title":"A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus","volume":"102","author":"Hawn","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2022.02.007_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: Diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2022.02.007_bib0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40744-021-00312-0","article-title":"Cognitive dysfunction in systemic lupus erythematosus: immunopathology, clinical manifestations, neuroimaging and management","volume":"8","author":"Seet","year":"2021","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.trsl.2022.02.007_bib0061","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/ndt\/gfv102","article-title":"Lupus nephritis management guidelines compared","volume":"31","author":"Wilhelmus","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2022.02.007_bib0062","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature07405","article-title":"The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor","volume":"456","author":"Ewald","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.02.007_bib0063","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Kuznik","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0064","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nature Reviews Rheumatol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000317","article-title":"Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America","volume":"6","author":"Wallace","year":"2019","journal-title":"Lupus Science & Medicine"},{"key":"10.1016\/j.trsl.2022.02.007_bib0066","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"American Academy of O. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.trsl.2022.02.007_bib0067","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"American Academy of O. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.trsl.2022.02.007_bib0068","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dmrr.2486","article-title":"Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment","volume":"30","author":"Hwang","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.trsl.2022.02.007_bib0069","first-page":"1922","article-title":"Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids","volume":"24","author":"Kipen","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0070","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jama.2019.8506","article-title":"Steroid side effects","volume":"322","author":"Grennan","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.trsl.2022.02.007_bib0071","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fphys.2017.00508","article-title":"Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics","volume":"8","author":"Gao","year":"2017","journal-title":"Frontiers in Physiol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0072","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/08916930903229239","article-title":"Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB\/W mice","volume":"43","author":"Graham","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.trsl.2022.02.007_bib0073","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1038\/s41598-017-06205-z","article-title":"Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes","volume":"7","author":"Stevens","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.trsl.2022.02.007_bib0074","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jphs.2019.04.006","article-title":"Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases","volume":"140","author":"Nishibori","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.trsl.2022.02.007_bib0075","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/med.21553","article-title":"Recent clinical trends in Toll-like receptor targeting therapeutics","volume":"39","author":"Anwar","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.trsl.2022.02.007_bib0076","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A new class of polymers: starburst-dendritic macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polymer Journal"},{"issue":"4","key":"10.1016\/j.trsl.2022.02.007_bib0077","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/molecules23040938","article-title":"Dendrimers for drug delivery","volume":"23","author":"Chauhan","year":"2018","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.trsl.2022.02.007_bib0078","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.3390\/molecules23112849","article-title":"New advances in general biomedical applications of PAMAM dendrimers","volume":"23","author":"Araujo","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.trsl.2022.02.007_bib0079","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nbt1023","article-title":"Antidote-mediated control of an anticoagulant aptamer in vivo","volume":"22","author":"Rusconi","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0080","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.1717705115","article-title":"Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer","volume":"115","author":"Powell Gray","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2022.02.007_bib0081","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nbt.4153","article-title":"Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass","volume":"36","author":"Gunaratne","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0082","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nm.1990","article-title":"Development of universal antidotes to control aptamer activity","volume":"15","author":"Oney","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2022.02.007_bib0083","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ymthe.2019.03.016","article-title":"Preclinical Development of a vWF aptamer to limit thrombosis and engender arterial recanalization of occluded vessels","volume":"27","author":"Nimjee","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2022.02.007_bib0084","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pharmtox-010716-104558","article-title":"Aptamers as therapeutics","volume":"57","author":"Nimjee","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.trsl.2022.02.007_bib0085","doi-asserted-by":"crossref","first-page":"14055","DOI":"10.1073\/pnas.1105777108","article-title":"Nucleic acid-binding polymers as anti-inflammatory agents","volume":"108","author":"Lee","year":"2011","journal-title":"Proceedings of the National Acad Sci"},{"key":"10.1016\/j.trsl.2022.02.007_bib0086","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.1204928109","article-title":"Nucleic acid scavengers inhibit thrombosis without increasing bleeding","volume":"109","author":"Jain","year":"2012","journal-title":"Proceedings of the National Acad Sci"},{"key":"10.1016\/j.trsl.2022.02.007_bib0087","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biomaterials.2016.12.024","article-title":"Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis","volume":"120","author":"Lee","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.trsl.2022.02.007_bib0088","doi-asserted-by":"crossref","first-page":"420e","DOI":"10.1097\/PRS.0000000000000471","article-title":"The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contraction","volume":"134","author":"Holl","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.trsl.2022.02.007_bib0089","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ymthe.2018.02.018","article-title":"Polymer-mediated inhibition of pro-invasive nucleic acid DAMPs and microvesicles limits pancreatic cancer metastasis","volume":"26","author":"Naqvi","year":"2018","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.trsl.2022.02.007_bib0090","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.ymthe.2020.12.026","article-title":"Controlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancer","volume":"29","author":"Holl","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2022.02.007_bib0091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2021.06.016","article-title":"Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucleic acid scavengers mitigate these effects","volume":"26","author":"Eteshola","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.trsl.2022.02.007_bib0092","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41467-018-06603-5","article-title":"Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation","volume":"9","author":"Liang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.02.007_bib0093","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1002\/anie.201813362","article-title":"Tuned cationic dendronized polymer: molecular scavenger for rheumatoid arthritis treatment","volume":"58","author":"Peng","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.trsl.2022.02.007_bib0094","doi-asserted-by":"crossref","first-page":"eabb5274","DOI":"10.1126\/sciadv.abb5274","article-title":"Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys","volume":"6","author":"Liang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.trsl.2022.02.007_bib0095","doi-asserted-by":"crossref","first-page":"e40862","DOI":"10.1371\/journal.pone.0040862","article-title":"The inhibition of anti-DNA binding to DNA by nucleic acid binding polymers","volume":"7","author":"Stearns","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.trsl.2022.02.007_bib0096","doi-asserted-by":"crossref","first-page":"e69413","DOI":"10.1371\/journal.pone.0069413","article-title":"Nucleic acid scavenging polymers inhibit extracellular DNA-mediated innate immune activation without inhibiting anti-viral responses","volume":"8","author":"Holl","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.trsl.2022.02.007_bib0097","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1073\/pnas.1607011113","article-title":"Scavenging nucleic acid debris to combat autoimmunity and infectious disease","volume":"113","author":"Holl","year":"2016","journal-title":"Proceedings of the National Acad Sci"},{"key":"10.1016\/j.trsl.2022.02.007_bib0098","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/0929867043456179","article-title":"Self-assembling nucleic acid delivery vehicles via linear, water-soluble, cyclodextrin-containing polymers","volume":"11","author":"Davis","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.trsl.2022.02.007_bib0099","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.trsl.2022.02.007_bib0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ymthe.2021.10.003","article-title":"beta-Cyclodextrin-containing polymer treatment of cutaneous lupus and influenza improves outcomes","volume":"30","author":"Kelly","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2022.02.007_bib0101","doi-asserted-by":"crossref","first-page":"18204","DOI":"10.1021\/jp0630830","article-title":"Molecular dynamics simulations of PAMAM dendrimer-induced pore formation in DPPC bilayers with a coarse-grained model","volume":"110","author":"Lee","year":"2006","journal-title":"The j physical chemistry B"},{"key":"10.1016\/j.trsl.2022.02.007_bib0102","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1166\/jctn.2009.1189","article-title":"Surface interaction and behavior of poly (amidoamine) dendrimers: deformability and lipid bilayer disruption","volume":"6","author":"Majoros","year":"2009","journal-title":"J computational and theoretical nanosci"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152442200041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152442200041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:44:40Z","timestamp":1761828280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152442200041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":102,"alternative-id":["S193152442200041X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2022.02.007","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting DAMPs with nucleic acid scavengers to treat lupus","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}